← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Artiva Biotherapeutics ARTV $296M	–	–	–	–
77	77 BioRestorative Therapies BRTX $2.02M	–	–	–	–
78	78 Candel Therapeutics CADL $682M	–	–	–	–
79	79 Creative Medical Technology CELZ $6.21M	–	–	–	–
80	80 DELISTED CERo Therapeutics CERO	–	–	–	–
81	81 Calidi Biotherapeutics CLDI $2.25M	–	–	–	–
82	82 Coya Therapeutics COYA $102M	–	–	–	–
83	83 Caribou Biosciences CRBU $49.8M	–	–	–	–
84	84 DELISTED CARGO Therapeutics CRGX	–	–	–	–
85	DBTX 85 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
86	86 enGene Therapeutics ENGN $115M	–	–	–	–
87	87 Estrella Immunopharma ESLA $23.3M	–	–	–	–
88	88 FibroBiologics FBLG $7.08M	–	–	–	–
89	89 4D Molecular Therapeutics FDMT $711M	–	–	–	–
90	FRLN 90 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
91	91 DELISTED Generation Bio GBIO	–	–	–	–
92	92 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
93	93 Genenta Science GNTA $32.3M	–	–	–	–
94	GRCL 94 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
95	GRML 95 Greenland Mines Ltd GRML $92.9M	–	–	–	–
96	96 Fractyl Health GUTS $55.2M	–	–	–	–
97	97 Immix Biopharma IMMX $720M	–	–	–	–
98	98 IN8bio INAB $11.7M	–	–	–	–
99	99 MiNK Therapeutics INKT $50.7M	–	–	–	–
100	100 Century Therapeutics IPSC $272M	–	–	–	–